Pharmaceutical Excipients and Drug Metabolism: A Mini-Review

被引:63
作者
Patel, Rahul [1 ]
Barker, James [1 ]
ElShaer, Amr [1 ]
机构
[1] Kingston Univ, Sch Life Sci Pharm & Chem, Drug Discovery Delivery & Patient Care DDDPC, Kingston Upon Thames KT1 2EE, Surrey, England
关键词
Pharmaceutical excipients; metabolism; cytochrome P450; HUMAN LIVER-MICROSOMES; GRAPEFRUIT JUICE COMPONENTS; IN-VITRO; FATTY-ACIDS; CYTOCHROME-P450; 3A; ORGANIC-SOLVENTS; CLINICAL PHARMACOKINETICS; ORAL BIOAVAILABILITY; NONIONIC SURFACTANTS; SOLUBILIZING AGENTS;
D O I
10.3390/ijms21218224
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Conclusions from previously reported articles have revealed that many commonly used pharmaceutical excipients, known to be pharmacologically inert, show effects on drug transporters and/or metabolic enzymes. Thus, the pharmacokinetics (absorption, distribution, metabolism and elimination) of active pharmaceutical ingredients are possibly altered because of their transport and metabolism modulation from the incorporated excipients. The aim of this review is to present studies on the interaction of various commonly-used excipients on pre-systemic metabolism by CYP450 enzymes. Excipients such as surfactants, polymers, fatty acids and solvents are discussed. Based on all the reported outcomes, the most potent inhibitors were found to be surfactants and the least effective were organic solvents. However, there are many factors that can influence the inhibition of CYP450, for instance type of excipient, concentration of excipient, type of CYP450 isoenzyme, incubation condition, etc. Such evidence will be very useful in dosage form design, so that the right formulation can be designed to maximize drug bioavailability, especially for poorly bioavailable drugs.
引用
收藏
页码:1 / 21
页数:21
相关论文
共 124 条
[1]   Making a case for domperidone in the treatment of gastrointestinal motility disorders [J].
Ahmad, Naveed ;
Keith-Ferris, Jeanne ;
Gooden, Elizabeth ;
Abell, Thomas .
CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (06) :571-576
[2]   IMPROVING INTESTINAL-ABSORPTION OF WATER-INSOLUBLE COMPOUNDS - A MEMBRANE METABOLISM STRATEGY [J].
AMIDON, GL ;
LEESMAN, GD ;
ELLIOTT, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (12) :1363-1368
[3]   PHARMACOKINETICS AND ORAL BIOAVAILABILITY OF PYRIDOSTIGMINE IN MAN [J].
AQUILONIUS, SM ;
ECKERNAS, SA ;
HARTVIG, P ;
LINDSTROM, B ;
OSTERMAN, PO .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (05) :423-428
[4]   Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions [J].
Backman, Janne T. ;
Filppula, Anne M. ;
Niemi, Mikko ;
Neuvonen, Pertti J. .
PHARMACOLOGICAL REVIEWS, 2016, 68 (01) :168-241
[5]   Grapefruit juice-drug interactions [J].
Bailey, DG ;
Malcolm, J ;
Arnold, O ;
Spence, JD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) :101-110
[6]   Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care [J].
Bennett, M ;
Lucas, V ;
Brennan, M ;
Hughes, A ;
O'Donnell, V ;
Wee, B .
PALLIATIVE MEDICINE, 2002, 16 (05) :369-374
[7]   In vitro killing of Candida albicans by fatty acids and monoglycerides [J].
Bergsson, G ;
Arnfinnsson, J ;
Steingrímsson, O ;
Thormar, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) :3209-3212
[8]  
Busby WF, 1999, DRUG METAB DISPOS, V27, P246
[9]  
Buse J., 2003, CLIN DIABETES, V21, P168, DOI DOI 10.2337/DIACLIN.21.4.168
[10]   Fatty Acid Based Microemulsions to Combat Ophthalmia Neonatorum Caused by Neisseria gonorrhoeae and Staphylococcus aureus [J].
Butt, Ummara ;
ElShaer, Amr ;
Snyder, Lori A. S. ;
Al-Kinani, Ali A. ;
Le Gresley, Adam ;
Alany, Raid G. .
NANOMATERIALS, 2018, 8 (01)